Kidney Cancer Trial, Recruiting (NCT05728957)

Kidney Cancer Trial, Recruiting NCT05728957 Sponsor: Loyola University Condition: Kidney Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT05728957 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Kidney Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with a kidney tumor that is confined to the kidney, measures 7cm or smaller, and appears suspicious for cancer on imaging scans
You have had, or are planning to have, a CT scan (with and without contrast dye) of the tumor within the past year
You are 18 years of age or older
Your doctor has said you are suitable for, or planning to have, surgery to remove part or all of the affected kidney
Your doctor has said you are suitable for, or planning to have, a biopsy (small tissue sample) of the kidney tumor
Your kidneys are functioning at an adequate level, based on a specific blood test that measures kidney filtering ability (confirm with trial site)

Who may not be able to join:

You are currently pregnant (as determined by the imaging center's local policy)
There is any evidence that your cancer has spread to lymph nodes or other parts of the body
You have a history of another type of cancer that may have spread to the kidney
You have a known allergy to technetium or sestamibi, which are substances used in certain medical imaging procedures

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Hiten D Patel, MD, MPH, Loyola University

Phone: 708-216-8467

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05728957

Sponsor: Loyola University

Phase: Not Applicable

Status: Recruiting

Condition: Kidney Cancer

Trial contact: 708-216-8467

More information: https://clinicaltrials.gov/study/NCT05728957

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with a kidney tumor that is confined to the kidney, measures 7cm or smaller, and appears suspicious for cancer on imaging scans
You have had, or are planning to have, a CT scan (with and without contrast dye) of the tumor within the past year
You are 18 years of age or older
Your doctor has said you are suitable for, or planning to have, surgery to remove part or all of the affected kidney
Your doctor has said you are suitable for, or planning to have, a biopsy (small tissue sample) of the kidney tumor
Your kidneys are functioning at an adequate level, based on a specific blood test that measures kidney filtering ability (confirm with trial site)

Who may not be able to join:

You are currently pregnant (as determined by the imaging center's local policy)
There is any evidence that your cancer has spread to lymph nodes or other parts of the body
You have a history of another type of cancer that may have spread to the kidney
You have a known allergy to technetium or sestamibi, which are substances used in certain medical imaging procedures

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Loyola University

Registry

ClinicalTrials.gov

Start date

1 February 2023

Est. completion

1 February 2033

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Histologic Classification (malignant vs. benign)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov